(ACMR) Acm Research - Overview
Sector: Technology | Industry: Semiconductor Equipment & Materials | Exchange: NASDAQ (USA) | Market Cap: 2.665m USD | Total Return: 151.7% in 12m
Industry Rotation: +23.4
Avg Turnover: 40.0M USD
Peers RS (IBD): 12.2
EPS Trend: -4.3%
Qual. Beats: 0
Rev. Trend: 82.1%
Qual. Beats: 0
Warnings
Volatile
Tailwinds
No distinct edge detected
ACM Research Inc. (ACMR) develops and sells capital equipment for the semiconductor industry. This includes wet cleaning equipment, a critical component in semiconductor manufacturing to remove defects from wafer surfaces. The company also offers advanced packaging tools, such as coaters and copper-plating tools, which are essential for the final stages of chip production. The semiconductor equipment sector is highly specialized, providing the machinery needed to produce integrated circuits.
ACMRs product portfolio features proprietary technologies like Ultra C SAPS and Ultra C TEBO for wafer cleaning, and Ultra-C Tahoe, designed for reduced chemical consumption. They also provide dry processing tools (Ultra fn Furnace) and PECVD tools (Ultra Pmax) for film deposition. The companys business model involves direct sales and third-party representatives to market its products globally. The semiconductor industry is characterized by rapid technological advancements and a high capital expenditure requirement from manufacturers.
To gain further insights into ACMRs financials and market position, consider exploring comprehensive data on ValueRay.
- Semiconductor capital equipment demand drives revenue growth
- Wafer cleaning technology adoption impacts market share
- Advanced packaging tool sales expand customer base
- Global chip manufacturing investment influences sales
- Supply chain disruptions affect production costs
| Net Income: 94.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -5.97 > 1.0 |
| NWC/Revenue: 187.6% < 20% (prev 107.7%; Δ 79.94% < -1%) |
| CFO/TA -0.00 > 3% & CFO -10.3m > Net Income 94.1m |
| Net Debt (-865.1m) to EBITDA (158.5m): -5.46 < 3 |
| Current Ratio: 3.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (68.8m) vs 12m ago 3.42% < -2% |
| Gross Margin: 44.39% > 18% (prev 0.50%; Δ 4.39k% > 0.5%) |
| Asset Turnover: 38.13% > 50% (prev 42.15%; Δ -4.02% > 0%) |
| Interest Coverage Ratio: 20.44 > 6 (EBITDA TTM 158.5m / Interest Expense TTM 6.96m) |
| A: 0.59 (Total Current Assets 2.44b - Total Current Liabilities 745.7m) / Total Assets 2.87b |
| B: 0.12 (Retained Earnings 350.4m / Total Assets 2.87b) |
| C: 0.06 (EBIT TTM 142.1m / Avg Total Assets 2.36b) |
| D: 0.37 (Book Value of Equity 348.9m / Total Liabilities 941.7m) |
| Altman-Z'' Score: 5.05 = AAA |
| DSRI: 1.12 (Receivables 552.9m/428.9m, Revenue 901.3m/782.1m) |
| GMI: 1.13 (GM 44.39% / 50.06%) |
| AQI: 0.75 (AQ_t 0.04 / AQ_t-1 0.05) |
| SGI: 1.15 (Revenue 901.3m / 782.1m) |
| TATA: 0.04 (NI 94.1m - CFO -10.3m) / TA 2.87b) |
| Beneish M-Score: -2.82 (Cap -4..+1) = A |
Over the past week, the price has changed by +14.04%, over one month by -1.18%, over three months by -6.20% and over the past year by +151.72%.
- StrongBuy: 4
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 70.5 | 52.8% |
P/E Forward = 24.2718
P/S = 2.9564
P/B = 1.816
Revenue TTM = 901.3m USD
EBIT TTM = 142.1m USD
EBITDA TTM = 158.5m USD
Long Term Debt = 178.9m USD (from longTermDebt, last quarter)
Short Term Debt = 113.9m USD (from shortTermDebt, last quarter)
Debt = 303.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -865.1m USD (recalculated: Debt 303.0m - CCE 1.17b)
Enterprise Value = 1.80b USD (2.66b + Debt 303.0m - CCE 1.17b)
Interest Coverage Ratio = 20.44 (Ebit TTM 142.1m / Interest Expense TTM 6.96m)
EV/FCF = -26.25x (Enterprise Value 1.80b / FCF TTM -68.5m)
FCF Yield = -3.81% (FCF TTM -68.5m / Enterprise Value 1.80b)
FCF Margin = -7.61% (FCF TTM -68.5m / Revenue TTM 901.3m)
Net Margin = 10.44% (Net Income TTM 94.1m / Revenue TTM 901.3m)
Gross Margin = 44.39% ((Revenue TTM 901.3m - Cost of Revenue TTM 501.2m) / Revenue TTM)
Gross Margin QoQ = 40.87% (prev 42.04%)
Tobins Q-Ratio = 0.63 (Enterprise Value 1.80b / Total Assets 2.87b)
Interest Expense / Debt = 0.59% (Interest Expense 1.79m / Debt 303.0m)
Taxrate = 31.60% (6.57m / 20.8m)
NOPAT = 97.2m (EBIT 142.1m * (1 - 31.60%))
Current Ratio = 3.27 (Total Current Assets 2.44b / Total Current Liabilities 745.7m)
Debt / Equity = 0.21 (Debt 303.0m / totalStockholderEquity, last quarter 1.46b)
Debt / EBITDA = -5.46 (Net Debt -865.1m / EBITDA 158.5m)
Debt / FCF = 12.62 (negative FCF - burning cash) (Net Debt -865.1m / FCF TTM -68.5m)
Total Stockholder Equity = 1.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.98% (Net Income 94.1m / Total Assets 2.87b)
RoE = 7.79% (Net Income TTM 94.1m / Total Stockholder Equity 1.21b)
RoCE = 10.25% (EBIT 142.1m / Capital Employed (Equity 1.21b + L.T.Debt 178.9m))
RoIC = 6.58% (NOPAT 97.2m / Invested Capital 1.48b)
WACC = 12.40% (E(2.66b)/V(2.97b) * Re(13.76%) + D(303.0m)/V(2.97b) * Rd(0.59%) * (1-Tc(0.32)))
Discount Rate = 13.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.53%
[DCF] Fair Price = unknown (Cash Flow -68.5m)
EPS Correlation: -4.31 | EPS CAGR: -37.83% | SUE: -1.99 | # QB: 0
Revenue Correlation: 82.09 | Revenue CAGR: 59.76% | SUE: 0.32 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.35 | Chg7d=-0.130 | Chg30d=-0.180 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=1.79 | Chg7d=-0.220 | Chg30d=-0.358 | Revisions Net=+0 | Growth EPS=+11.0% | Growth Revenue=+26.9%
EPS next Year (2027-12-31): EPS=2.28 | Chg7d=+0.110 | Chg30d=+0.110 | Revisions Net=-1 | Growth EPS=+27.6% | Growth Revenue=+23.1%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.4% (Discount Rate 13.8% - Earnings Yield 3.4%)
[Growth] Growth Spread = +14.7% (Analyst 25.1% - Implied 10.4%)